Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly’s Solanezumab Fails, But The Surprise Would Have Been Success

Related Content

Lilly Poised To Lead In Alzheimer’s, But Success Depends On Solanezumab

Dec 14 2015

Efficacy Signal For Lilly’s Solanezumab Stirs The Alzheimer’s Pot

Oct 15 2012

Lilly's Leap Tests Investors' Faith In Solanezumab

Mar 16 2016

Can New Drugs Meet Lilly’s Revenue Goals If Solanezumab Fails?

Oct 26 2016

Related Companies

Eli Lilly and Company

Merck & Co., Inc.

Biogen, Inc.

Additional Topics

Clinical Trials Commercial Neurology BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window